Hear from expert industry speakers at Oligonucleotide Therapeutics and Delivery 2021
SMi reports: Speakers confirmed at Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 22nd and 23rd September.
By: SMi Group
The Oligonucleotide Therapeutics and Delivery conference is here to keep you updated with discussions that will be centered around improving targeted therapy uniting the field's biggest players to share their opinions.
This year's agenda will encompass key drivers and hot topics of the industry including recent advances in oligonucleotide therapeutics, optimising oligonucleotide development strategies, clinical advances of RNAi therapy and emerging delivery solutions.
Registration is live on the website and an early bird saving of £200 will be applied to bookings made before 28th May 2021: www.oligonucleotide.co.uk/
Plus, an interactive half day pre-conference workshop:
Target Discovery for RNA Therapeutics
Workshop Leader: Martin Akerman, Chief Technology Officer, Envisagenics
Featured 2021 speakers include:
Chair for 2021
Nagy Habib, Professor of Surgery, Imperial College, Co-founder MiNA therapeutics, Imperial College London
The event brochure with the agenda and speaker line-up is available to download from the website; those interested in attending can register at: www.oligonucleotide.co.uk/
Proudly Sponsored by ChemGenes | Genscript | Tosoh Bioscience
For media queries please contact Jinna Sidhu at email@example.com or call +44 (0)20 7827 6088
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-